For years, activists and scientists have argued that the blood donation restrictions are discriminatory and unscientific. Now, the FDA is looking into relaxing those restrictions
Lukas Pietrzak first donated blood in 2013, when he was a high school student. The cause mattered to him because two units of donated blood had kept this father alive in the immediate aftermath of a cycling accident. They shared the same blood type, and if anything were to happen to his father again or to someone else, he wanted the chance to save their life too. But when Pietrzak participated in another blood donation drive later that same school year, it would be his last.
For years, activists and scientists have been advocating for revised blood donation rules linked to HIV transmission concerns and the FDA is nowIn 2015, the federal agency updated its policy to allow gay and bisexual men to donate blood, but only if they hadn’t had sex with another man for at least a year. In 2020, amid major blood shortages in the pandemic, the federal agency shortened that period to three months.
Over the years, Pietrzak grew resentful of the FDA rules. “They were excluding a group of otherwise eligible volunteers who wanted to give blood and basically saying because of who you are and who you’re with, we don’t want your blood,” he says.that commenced last year and considers whether donors could be assessed based on their individual HIV risks rather than sexual identity. “I’m hopeful this is a step toward an equitable blood donation policy,” Pietrzak says.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Why is strep A surging — and how worried are scientists?The tragic deaths of 13 children in England and an unusual rise in autumn cases have put researchers on alert.
Leer más »
FDA warns that LASIK surgery patients need to be better informed of risks before procedureThe surgery known as LASIK is under the lens of the Food and Drug Administration, which is causing controversy among eye experts.
Leer más »
U.S. FDA approves Mirati's lung cancer drugThe U.S. Food and Drug Administration on Monday approved Mirati Therapeutics Inc's lung cancer drug adagrasib, according to the health regulator's website, sending the company's shares up more than 8% in extended trading.
Leer más »
FDA warns that LASIK surgery patients need to be better informed of risks before eye procedureThe FDA released draft guidance on LASIK surgery, noting that patients considering the eye surgery should get a 'decision checklist' describing the procedure, plus a list of potential side effects.
Leer más »
US scientists set to announce fusion energy breakthroughScientists Tuesday are expected to announce a major advance in the long-running quest to harness fusion, the energy that powers the sun and stars.
Leer más »